pre-IPO PHARMA

COMPANY OVERVIEW

Decibel has built the world’s first comprehensive research, discovery and drug development platform dedicated to protecting and restoring hearing and balance. Our research platform provides the tools to deliver the right drugs to the right cells at the right dose.


LOCATION

  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Neurological Disorders

  • WEBSITE

    https://www.decibeltx.com


    CAREER WEBSITE

    https://www.decibeltx.com/join-us/


    SOCIAL MEDIA


    INVESTORS

    bessemer-trust foresite-capital gv regeneron schroder-adveq scubed-capital sr-one the-longevity-fund third-rock-ventures


    PRESS RELEASES


    Jan 29, 2021

    Decibel Therapeutics and Invitae Announce Launch of Amplify™ Genetic Testing Program


    Dec 17, 2020

    Decibel Therapeutics Announces DB-020 Has Been Granted Fast Track Designation by the U.S. Food and Drug Administration


    Nov 9, 2020

    Decibel Therapeutics Announces $82M Series D Financing to Advance Gene Therapies to Restore Hearing and Balance


    Nov 2, 2020

    Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology


    Sep 22, 2020

    Decibel Therapeutics Appoints Dr. Elisabeth Leiderman as Chief Financial Officer


    For More Press Releases


    Google Analytics Alternative